Managing the Acid and the Tumor: Treatment Options

Treating gastrinoma and Zollinger-Ellison Syndrome (ZES) requires a two-part strategy. You and your doctors must manage the “exhaust” (the dangerous stomach acid) while also deciding how to handle the “engine” (the tumor itself) ^[1].

Part 1: Managing the Acid (ZES)

The most immediate priority is stopping the massive overproduction of stomach acid. This is almost always done with high-dose Proton Pump Inhibitors (PPIs), such as omeprazole, pantoprazole, or lansoprazole ^[1].

• Individualized Dosing: Because your body produces far more acid than a person with typical reflux, you will likely need much higher doses—sometimes taken two or three times a day ^[1]. Your doctor may perform a test to measure your “basal acid output” to ensure the medication is working effectively ^[2].
• The “Never Stop” Rule: You must follow your clinician’s plan for missed doses and never abruptly stop or drastically reduce your PPI doses on your own. Without this protection, rebound acid hypersecretion can occur, potentially causing severe ulcers, bleeding, or perforation ^[3][4].
• Long-Term Monitoring: While PPIs are generally safe, taking high doses for many years may sometimes lead to low levels of Vitamin B12 or magnesium ^[5][6]. Your care team will individualize your monitoring based on your risks; routine testing is not automatically necessary for everyone but is often recommended.

Part 2: Managing the Tumor (Gastrinoma)

Once the acid is under control, the focus shifts to the tumor. The approach depends heavily on whether your gastrinoma is sporadic or related to MEN1.

Surgery for Sporadic Tumors

If your tumor is “sporadic” (not inherited) and is localized, surgery is generally considered and can sometimes offer a cure, though some patients may still need acid-reducing medication afterward ^[7][8]. Decisions depend on primary site, size, lymph nodes, and operative risk.

• Exploration: Because these tumors are often tiny and hard to see on scans, surgeons may perform a thorough “exploration” of the area where the pancreas and small intestine meet ^[2].
• Extent of Surgery: Depending on the tumor’s size and location, the surgeon may remove a small section of the duodenum (duodenotomy) or, in more complex cases, a portion of the pancreas ^[9][10].

The Debate Over MEN1 Surgery

For patients with MEN1, the decision is more complex. Because MEN1 often causes dozens of tiny tumors rather than just one, surgery is less likely to provide a permanent cure ^[11].

• Diverging Guidelines: Guidelines differ significantly: some international experts recommend surgery to prevent the tumors from spreading, while others recommend observation with PPIs if the tumors are small. These are not universal cutoffs ^[12][11].
• Personalized Choice: Your team will weigh your age, the size of your tumors, symptoms, acid control, and how they look on scans to decide if surgery is right for you ^[7].

Treatments for Advanced or Spread Disease

If the gastrinoma has spread (metastasized), usually to the liver or lymph nodes, other treatments are used to slow down the tumor’s growth:

• Somatostatin Analogs (SSAs): Medications like octreotide or lanreotide mimic a natural hormone that can slow the growth of neuroendocrine tumors ^[13]. Unlike PPIs, which stop the acid, SSAs are used to help control the tumor itself ^[14]. These generally require a well-differentiated, somatostatin-receptor-positive tumor.
• PRRT (Peptide Receptor Radionuclide Therapy): A specialized radiation treatment called Lu-177 DOTATATE. It involves an infusion that seeks out and attaches to the tumor cells, delivering radiation directly to them ^[15][16]. PRRT requires appropriate somatostatin-receptor expression and has meaningful toxicities, requiring kidney, marrow, and liver assessment.
• Cytotoxic Chemotherapy: For poorly differentiated neuroendocrine carcinomas (NECs) or high-grade tumors that do not express somatostatin receptors, systemic chemotherapy may be the preferred approach.
• Liver-Directed Therapies: If the tumors are mainly in the liver, doctors can use techniques like embolization (blocking the blood supply to the tumors) or ablation (using heat to destroy them) ^[17][18].

The Value of a Tumor Board

Because this condition is so rare, your care should ideally be managed by a multidisciplinary neuroendocrine tumor board ^[17]. This is a group of specialists—including surgeons, oncologists, gastroenterologists, and radiologists—who meet to review your specific case and ensure you are receiving the most current evidence-based care ^[19].